Skip to main content
Clinical Trials/CTRI/2019/12/022318
CTRI/2019/12/022318
Not yet recruiting
Phase 4

A prospective, comparative, randomized clinical study to compare and evaluate the safety, efficacy and refractive outcome of three different Hydrophilic Monofocal Intraocular Lens implanted to cataract patients. - BTVCPL-HFIOL-2019-02

Biotech Vision Care Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: H259- Unspecified age-related cataract
Sponsor
Biotech Vision Care Pvt Ltd
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Biotech Vision Care Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\.Unilateral/Bilateral Cataract
  • 2\.Patients with age \> 50 years.
  • 3\.Patients with Grade I or Grade II cataract as per Lens Opacities Classification System III (LOCS\-III).
  • 4\.Patients that have healthy eyes excluding the formation of senile cataract.
  • 5\.Patient who are ready to attended all the regular follow\-up examinations as per the routine schedule.

Exclusion Criteria

  • 1\.Patients receiving Chloroquine treatment.
  • 2\.Preoperative corneal astigmatism \> 1\.
  • 3\.Baseline endothelial cell density \< 1500 cells/mm2 in the operative eye.
  • 4\.Amblyopia, Microphthalmia, Glaucoma, Pseudoexfoliation Syndrome with Glaucoma, Iris atrophy, Proliferative diabetic retinopathy and all retinal pathologies.
  • 5\.A history of chronic or recurrent inflammatory eye disease (e.g. iritis, scleritis, uveitis, Iridocyclitis, rubeosis iritis).
  • 6\.Previous intra\-ocular or corneal surgery.
  • 7\.Pregnant or lactating mother.
  • 8\.Concurrent participation in another drug or device Study

Outcomes

Primary Outcomes

Not specified

Similar Trials